Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days
Author(s): Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
Issue: May/Jun 2020 - Volume 24, Number 3
View All Articles in Issue
Page(s): 246-251
Download in electronic PDF format for $75
Abstract: Commercially available oral liquid formulations of furosemide contain ethanol. However, ethanol can lead to toxicity, particularly in neonates and young children. This study’s objective was the development of ethanol-free furosemide suspensions and to determine whether suspending vehicles, temperature, and pH have an impact on the physical and chemical stability over a 30-day period. Formulations containing 2 mg/mL furosemide were prepared by crushing furosemide tablets and mixing with commercial vehicles Ora-Blend, Ora-Blend SF, or SyrSpend-SF Alka. As the stability of furosemide is reported to be pH-dependent, Ora-Blend and Ora-Blend SF were used both with and without pH adjustment. The resulting suspensions were stored at either 4oC or 25oC over 30 days with physical and chemical stability monitored. Negligible changes were noted in appearance over 30 days. The pH of all formulations remained relatively consistent throughout the study period. All formulations were chemically stable, as determined by high-performance liquid chromatography, retaining >90% of initial concentration over 30 days at 4oC and 25oC. Interestingly, suspensions remained chemically stable regardless of the pH of the vehicle, with the pH of the formulations ranging from 4.2 to 7.7. A simple extemporaneous compounding method was used to prepare alcohol-free furosemide suspensions that were stable for 30 days at 4oC and 25oC. These findings are important for patients who cannot tolerate, or wish to avoid, alcohol, including the pediatric population.
Related Keywords:
furosemide, loop diuretic, edema, fluid overload, chronic pulmonary disease, children, ethanol toxicity, adverse effects, alcohol free, oral suspensions, drug safety, physical stability, chemical stability
Related Categories:
EXCIPIENTS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, CARDIOLOGY, UROLOGY/URINARY TRACT
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Alcohol-free Extemporaneous Formulations of Furosemide Are Chemically and Physically Stable in Ora-Blend Products for 30 Days
Svirskis Darren, Jaffer Johaina, Agarwal Priyanka, Khan Ayeshah, Kaur Jaskarn, Cheng Alan, Hanning Sara
|
May/Jun 2020
Pg. 246-251
|
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
|
Jan/Feb 2018
Pg. 66-75
|
Stability of Furosemide 5 mg/mL in Polypropylene Syringes
van der Schaar JAJ, Grouls R, Franssen EJF, Crul M
|
Sep/Oct 2019
Pg. 414-417
|
Furosemide 5-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2022
Pg. 321-322
|
Furosemide 10-mg/mL Oral Suspension
Allen Loyd V Jr
|
Mar/Apr 2017
Pg. 148
|
Trihexyphenidyl Hydrochloride 1-mg/mL Oral Liquid, Alcohol-free
Allen Loyd V Jr
|
Jul/Aug 2023
Pg. 329
|
Hydrocortisone Acetate 1% Gel, Alcohol-Free
Allen Loyd V Jr
|
Jan/Feb 2011
Pg. 65
|
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R, Fox Samantha, Mixon William, Vail Jane
|
Jan/Feb 2012
Pg. 34-41
|
Theophylline 5-mg/mL Oral Liquid, Alcohol-Free
Allen Loyd V Jr
|
May/Jun 2006
Pg. 228
|
Cimetidine 60-mg/mL Oral Liquid, Alcohol Free
Allen Loyd V Jr
|
Mar/Apr 2006
Pg. 139
|
Oil and Alcohol Topical Vehicle (Preservative Free)
Allen Loyd V Jr
|
Nov/Dec 1998
Pg. 441
|
Dexamethasone and Furosemide Injection
Allen Loyd V Jr
|
Jul/Aug 2009
Pg. 335
|
Furosemide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2012
Pg. 158
|
Intravenous Physical Compatibility of Heparin Sodium and Furosemide
Maktabi Briana, Howard Mitchell S, Baki Gabriella, Churchwell Mariann D
|
Nov/Dec 2022
Pg. 522-526
|
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio, Lopedota Angela, Aurelio Fiorenza, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Sep/Oct 2021
Pg. 427-430
|
Hydroxyurea 100 mg/mL in Ora-Plus:Ora-Sweet, Ora-Plus: Ora-Sweet SF, Ora-Blend or Oral-Blend SF Oral Suspensions
Allen Loyd V Jr
|
Nov/Dec 2018
Pg. 496
|
Basics of Compounding for Cough
Allen Loyd V Jr
|
Nov/Dec 2004
Pg. 462-465
|
Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Patterson Donna, Ford Peter R, Gallon Marlene D
|
Jul/Aug 1997
Pg. 242-243
|
Waterless Alcohol-based Hand Sanitizers for the Compounding Pharmacy
Mixon William, Wood Adam P, Low Jennifer, Homan Linda
|
Jul/Aug 2011
Pg. 278-284
|
Alcohol Dehydrated Injection
Allen Loyd V Jr
|
Mar/Apr 2013
Pg. 145
|
Return to Top |